Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 3/20 | 0.60 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.46 |
| ▸ | NPC1 | O15118 | 3/20 | 0.46 |
| ▸ | RAB9A | P51151 | 3/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.46 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | CNR1 | P21554 | 2/20 | 0.41 |
| ▸ | CNR2 | P34972 | 2/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | KDM4A | O75164 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3520893 | 0.87 | PPARG (0.68) | PPARGTAAR1NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL3522291 | 0.86 | PPARG (0.80) | PPARGTAAR1NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL3522277 | 0.84 | PPARG (0.61) | PPARGTAAR1NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL3518457 | 0.82 | PPARG (0.61) | PPARGTAAR1NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL4504024 | 0.72 | NPC1 (0.56) | TAAR1NPC1RAB9ASMN1; SMN2EPHX2 | |
| SCHEMBL3599075 | 0.70 | PPARG (0.81) | PPARGTAAR1NPC1SMN1; SMN2TSHR | |
| SCHEMBL4515273 | 0.70 | L3MBTL1 (0.53) | PPARGTAAR1NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL4502645 | 0.70 | TSHR (0.50) | PPARGTAAR1NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL4506700 | 0.70 | TSHR (0.50) | PPARGTAAR1NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL4515901 | 0.70 | L3MBTL1 (0.45) | PPARGTAAR1NPC1RAB9ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8283349-B2 | Fungicide N-(3-phenylpropyl) carboxamide derivatives | BAYER CROPSCIENCE AG (DE) | 2012-10-09 | — | — | US | claimed |
| US-20100087494-A1 | FUNGICIDE N-(3-PHENYLPROPYL) CARBOXAMIDE DERIVATIVES | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2010-04-08 | — | — | US | claimed |
| EP-2125740-A1 | FUNGICIDE N-(3-PHENYLPROPYL)CARBOXAMIDE DERIVATIVES | Bayer CropScience SA (FR) | 2009-12-02 | — | — | EP | claimed |
| WO-2008101976-A1 | FUNGICIDE N-(3-PHENYLPROPYL)CARBOXAMIDE DERIVATIVES | BAYER CROPSCIENCE SA (FR) | 2008-08-28 | — | — | WO | claimed |
| US-8283349-B2 | Fungicide N-(3-phenylpropyl) carboxamide derivatives | BAYER CROPSCIENCE AG (DE) | 2012-10-09 | — | — | US | disclosed |
| US-20100087494-A1 | FUNGICIDE N-(3-PHENYLPROPYL) CARBOXAMIDE DERIVATIVES | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2010-04-08 | — | — | US | disclosed |
| EP-2125740-A1 | FUNGICIDE N-(3-PHENYLPROPYL)CARBOXAMIDE DERIVATIVES | Bayer CropScience SA (FR) | 2009-12-02 | — | — | EP | disclosed |
| WO-2008101976-A1 | FUNGICIDE N-(3-PHENYLPROPYL)CARBOXAMIDE DERIVATIVES | BAYER CROPSCIENCE SA (FR) | 2008-08-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100087494-A1 | FUNGICIDE N-(3-PHENYLPROPYL) CARBOXAMIDE DERIVATIVES | CYP51A1, CYP1A2, CYP3A7 | PPARG 331/4885TAAR1 3563/4885NPC1 809/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.